Shandong Dongyue Organosilicon Materials Co.Ltd(300821) : Announcement on the progress of trial production of raised investment projects

Securities code: 300821 securities abbreviation: Shandong Dongyue Organosilicon Materials Co.Ltd(300821) Announcement No.: 2022-003

Shandong Dongyue Organosilicon Materials Co.Ltd(300821)

Announcement on the progress of trial production of raised investment projects

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete

False records, misleading statements or material omissions.

Shandong Dongyue Organosilicon Materials Co.Ltd(300821) (hereinafter referred to as "the company") raised funds to invest in the project "300000 t / a silicone monomer and 200000 t / a silicone downstream product deep processing project" has entered the trial production stage on December 31, 2021. The company will arrange the trial production process in stages according to the product process and production process, For details, please refer to the announcement on trial production of raised investment projects (Announcement No.: 2021-074) disclosed by the company on cninfo.com. Now the progress of trial production of the project is announced as follows:

The "300000 t / a organosilicon monomer and 200000 t / a organosilicon downstream product deep processing project" has achieved phased results. The 300000 t / a organosilicon monomer device has successfully produced qualified organosilicon ring products on January 31, 2022. The subsequent company will actively promote the trial production of 200000 t / a organosilicon downstream product deep processing device.

The company's "300000 t / a silicone monomer and 200000 t / a silicone downstream product deep processing project" needs to arrange the trial production process in stages according to the product process and production process. It will take some time to get through each process in the trial production process, from trial production to large-scale production and release production capacity. In the early trial production stage, the stability of the production plant, product output and quality of the project needs to be continuously observed and improved, and the production may face potential risks. In the future, there may be risks such as changes in the market environment, intensified competition and fluctuations in product sales prices. Please make careful decisions and pay attention to investment risks.

It is hereby announced.

Shandong Dongyue Organosilicon Materials Co.Ltd(300821) board of directors February 7, 2022

- Advertisment -